MNTA
Momenta Pharmaceuticals, Inc.
MNTA
MNTA
Delisted
MNTA was delisted on the 30th of September, 2020.
147 hedge funds and large institutions have $1.42B invested in Momenta Pharmaceuticals, Inc. in 2019 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 82 increasing their positions, 29 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
147
Holders Change
-11
Holders Change %
-6.96%
% of All Funds
3.19%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
14
Increased
82
Reduced
29
Closed
25
Calls
$834K
Puts
$1.05M
Net Calls
-$216K
Net Calls Change
-$707K
Top Buyers
| 1 |
BlackRock
New York
|
+$20.2M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$9.57M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$8.61M |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
+$8.28M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$4.5M |
Top Sellers
| 1 |
D.E. Shaw & Co
New York
|
-$6.54M |
| 2 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$3.86M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$3.09M |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$3.05M |
| 5 |
LCM
Laurion Capital Management
New York
|
-$2.5M |
